Pharmacognosy Reviews logo
Submit
Pharmacognosy ReviewsACADEMIC PUBLISHING
Review

Reactualiting Phanera semibifida (Roxb.) Benth. from Sumatra, Indonesia as an Anticancer Agent and Phylogenetic Position

1, 2, 1, 1, 1

  1. 1Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Riau, INDONESIA.
  2. 2Plant Biology Graduate Program, Department of Biology, Faculty of Mathematic and Natural, IPB University, Bogor, West Java, INDONESIA.

CORRESPONDENCE

Fitmawati F

Department of Biology Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Riau, INDONESIA.

fitmawati2008@yahoo.com

Received: 26-11-2021; Accepted: 20-01-2022.

Volume 16, Issue 31 · pp. 34-39 · 2022 · DOI: 10.5530/phrev.2022.16.6

ABSTRACT

The increasing prevalence of cancer worldwide demands the intensification of efforts to develop natural solutions for its treatment. Herbal plants have provided a strong evident base in treating of this disease in many indigenous tribes in the world. Phanera semibifida has been widely used as a viable anti-degenerative drug for cancer treatment. This study reviews selected plant species with taxonomy status, phylogeny position, phytochemistry and pharmacology study based on a author’s research and literature review conducted through relevant keyword searches in databases, Web of Science, Scopus, PubMed, and Google Scholar. Detailed analysis of research studies proves that P. semibfida can be used as an anticancer agent with strong basic evidence based on indigenous knowledge from traditional communities.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    F, F., Juliantari, E., Roza, R. M., t, T., & Yahya, V. J. (2022). Reactualiting Phanera semibifida (Roxb.) Benth. from Sumatra, Indonesia as an Anticancer Agent and Phylogenetic Position. Pharmacognosy Reviews, 16(31), 34-39. https://doi.org/10.5530/phrev.2022.16.6

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to share and adapt the work for any purpose, as long as the original authors and source are credited. CC BY 4.0